5 hrs ago | Reuters
UPDATE 3-Biogen 4th-qtr profit up, outlook tops estimates
Biogen Idec Inc said on Tuesday its fourth-quarter earnings rose nearly 48 percent, driven by increased sales of its multiple sclerosis drugs and lower expenses.
Related Topix: Biotech, Medicine, Biogen, Healthcare Industry, Biogen Idec, Health, Cambridge, MA, Marketing
17 hrs ago | Globe and Mail
Hamilton researchers to test Italian scientist's MS theory
Caroline Alphonso Hamilton, Ont. - Published on Monday, Feb. 08, 2010 9:16PM EST R esearchers in Hamilton plan to begin patient trials evaluating the work of an Italian scientist whose intriguing treatment for multiple sclerosis has sparked both hope and controversy.
Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis .
Related Topix: Biotech, Teva Pharmaceutical Industries, Science / Technology, Marketing, Medicine, Pharmaceuticals, Healthcare Industry, Health, Food and Drug Administration
Multiple Sclerosis Experts Join Biogen Idec's Research and Development Team
Biogen Idec , a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced that John R. Richert, M.D., will be joining the Company as a Senior Fellow in Neurology Research and Development and Nancy D. Richert, M.D., Ph.D., will be joining as a Fellow in Neurology Research ...
Related Topix: Biotech, Biogen Idec, Medicine, Health, Georgetown University
FDA Drug Safety Communication: Risk of Progressive Multifocal...
FDA Drug Safety Communication: Risk of Progressive Multifocal Leukoencephalopathy with the use of Tysabri Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement [02-05-2010] The U.S. Food and Drug Administration is alerting the public that the risk of developing ...
Related Topix: Food and Drug Administration, Medicine, Health, Crohn's Disease
02/03/10 - Nutra Pharma Corp. Reports Fourth Quarter Sales
Nutra Pharma Corp. , a biotechnology company that is developing treatments for Adrenomyeloneuropathy , HIV and Multiple Sclerosis , has announced today that sales of its recently launched over-the-counter pain reliever , Cobroxin , totaled $583,955 for the fourth quarter ending December 31, 2009.
Related Topix: Biotech, Medicine, Healthcare Industry, HIV/AIDS
Blacks with MS have more severe symptoms, decline faster than whites
Fewer African Americans than Caucasians develop multiple sclerosis , statistics show, but their disease progresses more rapidly, and they don't respond as well to therapies, a new study by neurology researchers at the University at Buffalo has found.
Related Topix: Medicine, Health, African-American, SUNY Buffalo
FDA warns of brain risks with frequent Tysabri use
Federal health officials warned doctors Friday that the risk of a deadly brain inflammation linked to the multiple sclerosis treatment Tysabri increases with use of the drug.
Related Topix: Food and Drug Administration, Medicine, Health, Crohn's Disease
"The first tablets to fight multiple sclerosis dramatically reduce the chances of symptoms returning," The Daily Telegraph has reported.
Related Topix: Health, Leustatin, Cladribine (generic)
Campaign to fund MS research chair
Researchers in Saskatchewan have been working toward finding the cure for multiple sclerosis and now a new campaign is aimed at speeding up the process.
National MS Society Receives Multiple Awards
Ohio Valley Chapter Receives Three Awards to Continue Mission of Service and Research Cincinnati, OH - February 1, 2010 - The Ohio Valley Chapter of the National Multiple Sclerosis Society recently received three awards complimenting our efforts to mobilize people and resources to drive a cure while addressing the challenges of everyone affected by ...
Related Topix: Cincinnati, OH, Medicine, Health, Charitable Organizations, Family, Kids
The MS Read-A-Thon: Reading to End Multiple Sclerosis
After its official launch in November 2009, the 32nd edition of the MS Read-A-Thon, for the benefit of the Multiple Sclerosis Society of Canada, Quebec Division, is off to a promising start.
Reform Promises to Lower Bills for Chronic Illness
Health care advocates are trying to ensure that the final reform bill--which will be sent to President Obama in February--contains protections that will enable women with chronic conditions to afford ongoing care.
Related Topix: US News, US Senate, Edward Kennedy, Democrat, Medicine, Health, Diabetes
Women-XtraEdition - Indiatimes
Multiple sclerosis risk changes with season
A new study has revealed that the risk of developing multiple sclerosis changes with the season.
Regis Technologies Passes FDA Pre-Approval Inspection For Acorda...
Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients and intermediates, announced it has received an Establishment Inspection Report from the U.S. Food and Drug Administration stating that Regis passed the FDA's pre-approval inspection for its manufacture of ...
Related Topix: Food and Drug Administration, Medicine, Health
Robert Douglas Jensen, age 79, of Catonsville, MD, died Thursday, January 21, 2010, due to complications of multiple sclerosis.
Related Topix: Catonsville, MD, Medicine, Health, Baltimore, MD, Westfield (Baltimore, MD), Cornell University, Silver Spring, MD
Scientists find survival factor for keeping nerve cells healthy
Scientists at the Babraham Institute have discovered a novel survival factor whose rapid transport along nerve cells is crucial for keeping them alive.
FDA announces recall of 2M defective needles
The following recalls have been announced: -Nipro Medical Corp. of Miami is recalling all GlucoPro Insulin Syringes with expiration dates before Nov.
Related Topix: Food and Drug Administration, 9, Medicine, Health, Biotech, Johnson and Johnson, Healthcare Industry, Arthritis
Interview: Finding answers in blood
Chemical biology news from across RSC Publishing. Interview: Finding answers in blood 27 January 2010 Dana Spence discusses the function of red blood cells and the importance of a foundation in chemistry with Jane Hordern Dana Spence is an associate professor at Michigan State University, East Lansing, US specialising in quantitative biological ...
Related Topix: Chemistry, Science, Michigan State University, Medicine, Diabetes, Health, Medication, Insulin (generic), Humulin, Novolin
US Approves Acorda Therapeutics MS Drug to Help with Walking
Acorda Therapeutics, Inc. today announced that it has received marketing approval from the U.S. Food and Drug Administration for AMPYRATM , an oral treatment to improve walking in patients with multiple sclerosis .
Related Topix: Biotech, Medicine, Healthcare Industry, Acorda Therapeutics, Food and Drug Administration, Healthcare Law, Law, Marketing, Health
Also on Topix
46 min ago | CNN
Endeavour docks with space station
59 min ago | ABC
China Exports Show Trade Recovery on Track
1 hr ago | NY Times
Afghanistan: Anti-Poppy Campaignhas Failed, United Nation...
1 hr ago | CNN
Repressed voices speak out in Iran
1 hr ago | USA Today
Obama's aim on health care: Mesh 'best ideas'
2 hrs ago | LA Times
Michael Jackson's doctor's case may hinge on his police s...
3 hrs ago | CNN
Haiti rubble collapse traps at least one
8 hrs ago | CBS
Super Bowl Ad Mends Leno-Letterman Tiff
12 hrs ago | ABC
White House Mocks Sarah Palin From Podium
17 hrs ago | WSJ
Secondary Sources: Consumer Agency, Euro Crisis, Climate ...
Recent activity of our hottest topics
Wauconda, IL
Keira Knightley
The Bachelor
Middletown, CT
Plantation, FL
Maggie Valley, NC
Marion, VA
Cooper, TX
Air Accidents
Advance, MO
Jimmy Spencer
Everett, MA

• Flag inappropriate postPost has been flagged for review
• Priority Review request ($19.99)
• Cancel
Change location for your local news
Current location: Lumberton, TX
International users, click here to set your location.
What is Topix?
Topix is the largest news community on the web.
We take news from over 60,000 sources and categorize those stories to over 40,600 locations and 450,000 topics.
Topix breaks the mold of traditional news sites by allowing our users to edit the news. We've built a suite of editing tools, so Topix users can make sure all the stories that matter get the attention they deserve.
The best part? You can comment on everything. Every story, every poll, every user-submitted photo.
Jump in, find a topic and start talking!
By the way, if you're interested in learning more about Topix, visit our blog.